Glimepiride Metformin Hydrochloride Tablet

Product Description

Glimepiride + Metformin Hydrochloride Tablets

Composition:
Each uncoated bilayered tablet contains:

• Glimepiride 1 mg / 2 mg / 4 mg (as per strength)

• Metformin Hydrochloride 500 mg / 850 mg / 1000 mg (Sustained Release or Immediate Release as per formulation)

---

Description:

A rational fixed-dose combination of Glimepiride, a sulfonylurea that stimulates insulin release, and Metformin, a biguanide that reduces hepatic glucose production and improves insulin sensitivity. This combination provides complementary mechanisms to effectively manage blood glucose levels in patients with Type 2 Diabetes Mellitus (T2DM).

---

Indications:

• Type 2 Diabetes Mellitus (T2DM)

• Patients inadequately controlled on monotherapy

• First-line dual therapy in insulin-resistant patients

---

Benefits:

Dual mechanism for optimal glycemic control
Improves insulin sensitivity and -cell response
Reduces fasting and postprandial blood glucose levels
Convenient once or twice-daily dosing

---

Dosage:

As prescribed by the physician.
Usually taken once or twice daily, preferably with meals to minimize GI upset.

---

Storage:

Store in a cool, dry place. Protect from light and moisture.

Dual Action for Diabetes Management

Metformin and Glimepiride together provide a synergistic effect to control blood glucose. While Metformin assists by reducing glucose production in the liver, Glimepiride stimulates insulin release. This dual mechanism offers comprehensive diabetes care for patients, maximizing the benefits of each component.


Strict Storage for Stability

For optimal stability and potency, Glimepiride Metformin Hydrochloride Tablets should be stored in a cool, dry, and dark environment. Adhering to these guidelines helps maintain their effectiveness throughout the 36-month shelf life, ensuring patients receive maximum therapeutic benefit.